Skip to main content
Erschienen in: Journal of General Internal Medicine 3/2021

14.01.2021 | COVID-19 | Original Research Zur Zeit gratis

Post-Discharge Health Status and Symptoms in Patients with Severe COVID-19

verfasst von: Himali Weerahandi, MD, MPH, Katherine A. Hochman, MD, MBA, Emma Simon, BS, Caroline Blaum, MD, Joshua Chodosh, MD, MSHS, Emily Duan, BA, Kira Garry, MPH, Tamara Kahan, BA, Savannah L. Karmen-Tuohy, BS, Hannah C. Karpel, MS, Felicia Mendoza, BA, Alexander M. Prete, BS, Lindsey Quintana, BS, Jennifer Rutishauser, BS, Leticia Santos Martinez, MPH, Kanan Shah, BS, Sneha Sharma, BS, Elias Simon, BA, Ana Z. Stirniman, BA, Leora I. Horwitz, MD, MHS

Erschienen in: Journal of General Internal Medicine | Ausgabe 3/2021

Einloggen, um Zugang zu erhalten

Abstract

Background

Little is known about long-term recovery from severe COVID-19 disease. Here, we characterize overall health, physical health, and mental health of patients 1 month after discharge for severe COVID-19.

Methods

This was a prospective single health system observational cohort study of patients ≥ 18 years hospitalized with laboratory-confirmed COVID-19 disease who required at least 6 l of oxygen during admission, had intact baseline cognitive and functional status, and were discharged alive. Participants were enrolled between 30 and 40 days after discharge. Outcomes were elicited through validated survey instruments: the PROMIS® Dyspnea Characteristics and PROMIS® Global Health-10.

Results

A total of 161 patients (40.6% of eligible) were enrolled; 152 (38.3%) completed the survey. Median age was 62 years (interquartile range [IQR], 50–67); 57 (37%) were female. Overall, 113/152 (74%) participants reported shortness of breath within the prior week (median score 3 out of 10 [IQR 0–5]), vs 47/152 (31%) pre-COVID-19 infection (0, IQR 0–1), p < 0.001. Participants also rated their physical health and mental health as worse in their post-COVID state (43.8, standard deviation 9.3; mental health 47.3, SD 9.3) compared to their pre-COVID state, (54.3, SD 9.3; 54.3, SD 7.8, respectively), both p < 0.001. Physical and mental health means in the general US population are 50 (SD 10). A total of 52/148 (35.1%) patients without pre-COVID oxygen requirements needed home oxygen after hospital discharge; 20/148 (13.5%) reported still using oxygen at time of survey.

Conclusions

Patients with severe COVID-19 disease typically experience sequelae affecting their respiratory status, physical health, and mental health for at least several weeks after hospital discharge.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat CDC COVID-19 Response Team. Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) - United States, February 12-March 16, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(12):343-346.CrossRefPubMedCentral CDC COVID-19 Response Team. Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) - United States, February 12-March 16, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(12):343-346.CrossRefPubMedCentral
2.
Zurück zum Zitat Petrilli CM, Jones SA, Yang J, et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ 2020;369:m1966.PubMedPubMedCentral Petrilli CM, Jones SA, Yang J, et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ 2020;369:m1966.PubMedPubMedCentral
3.
Zurück zum Zitat Richardson S, Hirsch JS, Narasimhan M, et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA 2020;323(20):2052-2059.CrossRefPubMedPubMedCentral Richardson S, Hirsch JS, Narasimhan M, et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA 2020;323(20):2052-2059.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395(10229):1054-1062.CrossRefPubMedPubMedCentral Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395(10229):1054-1062.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Goyal P, Choi JJ, Pinheiro LC, et al. Clinical Characteristics of Covid-19 in New York City. N Engl J Med 2020;382(24):2372-2374.CrossRefPubMed Goyal P, Choi JJ, Pinheiro LC, et al. Clinical Characteristics of Covid-19 in New York City. N Engl J Med 2020;382(24):2372-2374.CrossRefPubMed
6.
Zurück zum Zitat Montalvan V, Lee J, Bueso T, De Toledo J, Rivas K. Neurological manifestations of COVID-19 and other coronavirus infections: A systematic review. Clin Neurol Neurosurg 2020;194:105921-105921.CrossRefPubMedPubMedCentral Montalvan V, Lee J, Bueso T, De Toledo J, Rivas K. Neurological manifestations of COVID-19 and other coronavirus infections: A systematic review. Clin Neurol Neurosurg 2020;194:105921-105921.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Helms J, Tacquard C, Severac F, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med 2020;46(6):1089-1098.CrossRefPubMedPubMedCentral Helms J, Tacquard C, Severac F, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med 2020;46(6):1089-1098.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Klok FA, Kruip MJHA, van der Meer NJM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res 2020;191:145-147.CrossRefPubMedPubMedCentral Klok FA, Kruip MJHA, van der Meer NJM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res 2020;191:145-147.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Carfi A, Bernabei R, Landi F, Gemelli Against Covid-Post-Acute Care Study Group. Persistent Symptoms in Patients After Acute COVID-19. JAMA 2020;324(6):603-605.CrossRefPubMedPubMedCentral Carfi A, Bernabei R, Landi F, Gemelli Against Covid-Post-Acute Care Study Group. Persistent Symptoms in Patients After Acute COVID-19. JAMA 2020;324(6):603-605.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Garrigues E, Janvier P, Kherabi Y, et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Inf 2020. Published online first 2020/08/28 Garrigues E, Janvier P, Kherabi Y, et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Inf 2020. Published online first 2020/08/28
11.
Zurück zum Zitat Griffiths RD, Jones C. Recovery from intensive care. BMJ (Clinical research ed) 1999;319(7207):427-429.CrossRef Griffiths RD, Jones C. Recovery from intensive care. BMJ (Clinical research ed) 1999;319(7207):427-429.CrossRef
12.
Zurück zum Zitat Belluck P. As Body Fights, Virus Splinters Patients’ Minds. The New York Times, June 29, 2020:A1 Belluck P. As Body Fights, Virus Splinters Patients’ Minds. The New York Times, June 29, 2020:A1
13.
Zurück zum Zitat Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009;42(2):377-381.CrossRefPubMed Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009;42(2):377-381.CrossRefPubMed
14.
Zurück zum Zitat Cella D, Yount S, Rothrock N, et al. The Patient-Reported Outcomes Measurement Information System (PROMIS): progress of an NIH Roadmap cooperative group during its first two years. Med Care 2007;45(5 Suppl 1):S3-S11.CrossRefPubMedPubMedCentral Cella D, Yount S, Rothrock N, et al. The Patient-Reported Outcomes Measurement Information System (PROMIS): progress of an NIH Roadmap cooperative group during its first two years. Med Care 2007;45(5 Suppl 1):S3-S11.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Belluck P. Some Survivors of Covid-19 Face Slew of Challenges After Hospitalization. The New York Times, July 2, 2020:A6. Belluck P. Some Survivors of Covid-19 Face Slew of Challenges After Hospitalization. The New York Times, July 2, 2020:A6.
21.
Zurück zum Zitat Tenforde MW, Kim SS, Lindsell CJ, et al. Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network - United States, March-June 2020. MMWR Morb Mortal Wkly Rep 2020;69(30):993-998.CrossRefPubMedPubMedCentral Tenforde MW, Kim SS, Lindsell CJ, et al. Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network - United States, March-June 2020. MMWR Morb Mortal Wkly Rep 2020;69(30):993-998.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat World Health Organization. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). 2/28/2020 2020. World Health Organization. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). 2/28/2020 2020.
23.
Zurück zum Zitat Needham DM, Davidson J, Cohen H, et al. Improving long-term outcomes after discharge from intensive care unit: report from a stakeholders' conference. Crit Care Med 2012;40(2):502-509.CrossRefPubMed Needham DM, Davidson J, Cohen H, et al. Improving long-term outcomes after discharge from intensive care unit: report from a stakeholders' conference. Crit Care Med 2012;40(2):502-509.CrossRefPubMed
25.
Zurück zum Zitat Krumholz HM. Post-Hospital Syndrome — An Acquired, Transient Condition of Generalized Risk. N Eng J Med 2013;368(2):100–102. Krumholz HM. Post-Hospital Syndrome — An Acquired, Transient Condition of Generalized Risk. N Eng J Med 2013;368(2):100–102.
26.
Zurück zum Zitat Herridge MS, Tansey CM, Matté A, et al. Functional Disability 5 Years after Acute Respiratory Distress Syndrome. N Eng J Med 2011;364(14):1293–1304. Herridge MS, Tansey CM, Matté A, et al. Functional Disability 5 Years after Acute Respiratory Distress Syndrome. N Eng J Med 2011;364(14):1293–1304.
27.
Zurück zum Zitat Ngai JC, Ko FW, Ng SS, To K-W, Tong M, Hui DS. The long-term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity and health status. Respirology. 2010;15(3):543-550.CrossRefPubMedPubMedCentral Ngai JC, Ko FW, Ng SS, To K-W, Tong M, Hui DS. The long-term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity and health status. Respirology. 2010;15(3):543-550.CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Hui DS, Ko FW, Chan DP, et al. The long-term impact of severe acute respiratory syndrome (SARS) on pulmonary function, exercise capacity, and quality of life in a cohort of survivors. Chest 2005;128(4):148S-148S.CrossRef Hui DS, Ko FW, Chan DP, et al. The long-term impact of severe acute respiratory syndrome (SARS) on pulmonary function, exercise capacity, and quality of life in a cohort of survivors. Chest 2005;128(4):148S-148S.CrossRef
29.
Zurück zum Zitat Kamdar BB, Suri R, Suchyta MR, et al. Return to work after critical illness: a systematic review and meta-analysis. Thorax 2020;75(1):17-27.CrossRefPubMed Kamdar BB, Suri R, Suchyta MR, et al. Return to work after critical illness: a systematic review and meta-analysis. Thorax 2020;75(1):17-27.CrossRefPubMed
31.
Zurück zum Zitat Landi F, Gremese E, Bernabei R, et al. Post-COVID-19 global health strategies: the need for an interdisciplinary approach. Aging Clin Exp Res. 2020 Aug;32(8):1613–1620. Landi F, Gremese E, Bernabei R, et al. Post-COVID-19 global health strategies: the need for an interdisciplinary approach. Aging Clin Exp Res. 2020 Aug;32(8):1613–1620.
32.
Zurück zum Zitat Caraballo C, Khera R, Jones PG, et al. Rates and Predictors of Patient Underreporting of Hospitalizations During Follow-Up After Acute Myocardial Infarction: An Assessment From the TRIUMPH Study. Circ Cardiovasc Qual Outcomes 2020;13:e006231. Caraballo C, Khera R, Jones PG, et al. Rates and Predictors of Patient Underreporting of Hospitalizations During Follow-Up After Acute Myocardial Infarction: An Assessment From the TRIUMPH Study. Circ Cardiovasc Qual Outcomes 2020;13:e006231.
Metadaten
Titel
Post-Discharge Health Status and Symptoms in Patients with Severe COVID-19
verfasst von
Himali Weerahandi, MD, MPH
Katherine A. Hochman, MD, MBA
Emma Simon, BS
Caroline Blaum, MD
Joshua Chodosh, MD, MSHS
Emily Duan, BA
Kira Garry, MPH
Tamara Kahan, BA
Savannah L. Karmen-Tuohy, BS
Hannah C. Karpel, MS
Felicia Mendoza, BA
Alexander M. Prete, BS
Lindsey Quintana, BS
Jennifer Rutishauser, BS
Leticia Santos Martinez, MPH
Kanan Shah, BS
Sneha Sharma, BS
Elias Simon, BA
Ana Z. Stirniman, BA
Leora I. Horwitz, MD, MHS
Publikationsdatum
14.01.2021
Verlag
Springer International Publishing
Erschienen in
Journal of General Internal Medicine / Ausgabe 3/2021
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-020-06338-4

Weitere Artikel der Ausgabe 3/2021

Journal of General Internal Medicine 3/2021 Zur Ausgabe

Passend zum Thema

ANZEIGE

IPD-Fallzahlen & Pneumokokken-Impfung bei Kindern in Deutschland

Das Niveau der postpandemischen Fallzahlen für invasive Pneumokokken-Erkrankungen (IPD) ist aus Sicht des Referenz-Zentrums für Streptokokken in Aachen alarmierend [1]. Wie sich die monatlichen IPD-Fallzahlen bei Kindern und Jugendlichen von Juli 2015 bis März 2023 entwickelt haben, lesen Sie hier.

ANZEIGE

HPV-Impfung: Auch für junge Erwachsene sinnvoll und wichtig

Auch nach dem 18. Lebensjahr kann eine HPV-Impfung sinnvoll und wichtig sein. Viele gesetzliche Krankenkassen übernehmen die Kosten auch zu einem späteren Zeitpunkt noch.

ANZEIGE

Impfstoffe – Krankheiten vorbeugen, bevor sie entstehen

Seit mehr als 130 Jahren entwickelt und produziert MSD Impfstoffe für alle Altersgruppen. Hier finden Sie nützliche Informationen und Praxismaterialien rund um das Thema Impfen.

MSD Sharp & Dohme GmbH

Passend zum Thema

ANZEIGE

COPD und nicht-invasive Behandlungsmethoden

Content Hub

Nicht-medikamentöse Behandlungsmethoden wie die nicht-invasive Beatmung (NIV) können die Leistungsfähigkeit und Lebensqualität von COPD-Patienten erheblich verbessern und das Sterberisiko senken. Die NIV-Therapie zur Behandlung von fortgeschrittener COPD hat Eingang in die neuen S2k-Leitlinien zur COPD-Therapie gefunden.

ResMed Germany Inc.
ANZEIGE

Geringere Therapieabbruchquoten durch digitale Therapiebegleitung

Ärzte profitieren von digitaler Therapiebegleitung ihrer NIV-Patienten durch einen verlässlichen Partner, weil diese sich besser versorgt fühlen und die Therapie weniger häufig abbrechen. Das entlastet das Gesundheitssystem und schwer Erkrankte gewinnen Lebensqualität.

ANZEIGE

Auch für ältere Patienten empfiehlt sich nicht-invasive Langzeitbeatmung

Nicht-invasive Beatmung ist für Menschen mit chronisch hyperkapnisch respiratorischer Insuffizienz eine bewährte Therapie. Eine Schweizer Studie untersuchte die Auswirkungen der Beatmung auf über 75-Jährige und belegt nun deren Wirksamkeit.